LIMITED LIABILITY COMPANY INTEREST PURCHASE AGREEMENT by and among QUEST DIAGNOSTICS INCORPORATED, OXFORD IMMUNOTEC LIMITED, OXFORD IMMUNOTEC, INC. and Solely for the purposes of Section 5.4, Section 5.6, Section 5.12, Section 5.16, Article VII and...Limited Liability Company Interest Purchase Agreement • September 25th, 2018 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • Delaware
This LIMITED LIABILITY COMPANY INTEREST PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of September 25, 2018, by and among (i) Quest Diagnostics Incorporated, a Delaware corporation (the “Buyer”), (ii) Oxford Immunotec Limited, a limited company incorporated in England and Wales (“Olive”), (iii) Oxford Immunotec, Inc., a Delaware corporation (the “Company”), and (iv) solely for the purposes of Section 5.4, Section 5.6, Section 5.12, Section 5.16, Article VII and Article IX, Oxford Immunotec Global PLC, a public limited company incorporated in England and Wales (“Parent”). The Company, the Buyer, Olive and Holdco (as defined below) are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.” Certain capitalized terms used herein are defined in Annex I.
